Jiangsu Hengrui Medicine Company Description
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally.
The company develops antineoplastic drugs; surgery medications; medicines for oncology, autoimmune diseases, pain management, metabolic diseases, cardiovascular diseases, infectious diseases, respiratory system diseases, hematological diseases, neurological diseases, and ophthalmology, etc.; analgesia and anesthesia products; and contrast agents.
It is also involved in technical consulting; training; investment advisory; technology development; project; information; and investing services, as well as the import and export of pharmaceutical products.
Jiangsu Hengrui Medicine Co., Ltd. was founded in 1970 and is headquartered in Lianyungang City, China.
Country | China |
Founded | 1970 |
Industry | Drug Manufacturers - General |
Sector | Healthcare |
Employees | 19,611 |
CEO | Hong Bin Dai |
Contact Details
Address: No. 38, Huanghe Road Lianyungang City, Liaoning Province 222000 China | |
Phone | 86 40 0828 3900 |
Website | hengrui.com |
Stock Details
Ticker Symbol | 600276 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE0000014W7 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Hong Bin Dai | GM and Director |
Jianjun Liu | Financial Director |
Jie Ping Sun | Deputy GM and Director |
Dr. Lian Shan Zhang Ph.D. | Deputy GM and Director |
Dr. Ningjun Jiang M.D., Ph.D. | Deputy GM and Director |
Xiao Han Liu | Secretary of the Board of Directors |
Su Mei Jiang | Deputy General Manager |
Ya Ping Shen | Deputy General Manager |
Cheng Liao | Deputy General Manager |
Hongsen Wang | Deputy General Manager |